Teva Pharmaceutical Industries Ltd ADR buy The Goldman Sachs Group, Inc.
Start price
08.12.25
/
50%
€24.40
Target price
08.12.26
€26.60
Performance (%)
13.11%
Price
17.04.26
€27.60
Summary
This prediction is currently active. The prediction currently has a performance of 13.11%. This prediction currently runs until 08.12.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Teva Pharmaceutical Industries Ltd ADR | 4.943% | 4.943% |
| iShares Core DAX® | 3,59 % | 3,93 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % |
| iShares S&P 500 | 4,14 % | 4,04 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Teva Pharmaceutical Industries Ltd ADR diskutieren
Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $28.00 to $31.00. They now have a "buy" rating on the stock.
Ratings data for TEVA provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Teva Pharmaceutical Industries Ltd ADR
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€28.80
09.02.26
09.02.26
€38.07
09.02.27
09.02.27
-4.17%
17.04.26
17.04.26
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€25.90
19.12.25
19.12.25
€29.84
19.12.26
19.12.26
6.56%
17.04.26
17.04.26
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€15.15
06.06.25
06.06.25
€20.97
06.06.26
06.06.26
82.18%
17.04.26
17.04.26